Advancing Care for Your Patients With Epilepsy
If you treat patients with epilepsy, the POWER1 study may be an opportunity for those seeking a new investigational treatment option. Vormatrigine, the investigational medicine being studied, is designed to target seizures with a novel mechanism of action.
Connect with our medical team
If you’re a US healthcare professional and are interested in speaking with a member of the Praxis medical team to hear more about the study, please provide your contact information. A member of our team will reach out to you shortly.